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ABSTRACT 
 
The cell cycle machinery consists of regulatory proteins that 
control the progression through the cell cycle ensuring that 
DNA replication alternates with DNA segregation in mitosis to 
maintain cell integrity. Some of these key regulators have to be 
degraded at each cell cycle to prevent cellular dysfunction. 
Mitotic exit requires the inactivation of cyclin dependent 
kinase1 (cdk1) and it is the degradation of the cyclin subunit 
that inactivates the kinase. Cyclin degradation has been well 
characterized and it was shown that it is ubiquitin proteasome 
pathway that leads to the elimination of cyclins. By now, many 
other regulatory proteins were shown to be degraded by the 
same pathway, among them members of the aurora kinase 
family, degraded many other regulatory proteins. Aurora 
kinases are involved in mitotic spindle formation as well as in 
cytokinesis. The abundance and activity of the kinase is 
precisely regulated during the cell cycle. To understand how 
proteolysis regulates transitions through the cell cycle we 
describe two assays for ubiquitination and degradation of 
xenopus aurora kinase A using extracts from xenopus eggs or 
somatic cell lines. 
 
INTRODUCTION 
 
The ubiquitin/proteasome pathway is the major proteolytic 
system in the eukaryotic cell for selective degradation of short 
lived regulatory proteins (1,2). This pathway  consists of a 
ubiquitin activating enzyme (E1) a ubiquitin conjugating 
enzyme (E2) and a ubiquitin ligase (E3). The 26S proteasome 
then degrades the ubiquitinated proteins (3,4). 
 
The common feature of proteasome mediated protein 
degradation is the covalent attachment of ubiquitin, a 76 amino 
acids protein, to an epsilon amino-group of lysin residues of 
proteins targeted for degradation. Repeated addition of 
ubiquitin molecules to the substrate leads to the formation of 
polyubiquitin chains that are recognized by the 26S Proteasome 
(5). In contrast to the E1 and E2 enzymes the E3 ubiquitin 
ligases display substrate specificity. The E3 enzyme for the 
ubiquitination of several mitotic proteins has been purified 
from Xenopus egg extracts and called APC/C (Anaphase 
Promoting Complex/Cyclosome) (6). The activity of APC is 
regulated by two additional proteins, cdc20 and cdh1. While 
cdc20 is a mitosis specific activator, cdh1 maintains APC 
activity in G1 phase (7,8). Most known substrates of APC 
contain a destruction box (D box) and are degraded in mitosis 
or G1 phase of the cell cycle. The Cdc20 dependent pathway 
targets proteins that possess a cyclin-like “destruction box” 
which sequence contains two invariable conserved residues, an 
arginine and a leucine, separated by two amino-acids (9). The 
minimal required sequence RxxL is generally localized in the 
N-terminal domain of the protein (9,10). The “D boxes” have 
been also found to be important for several non-cyclin proteins 
that are mitosis-specifically ubiquitinated and degradated (11-
13). 
 
For example, the mitotic aurora-A kinase whose over-
expression is detected in tumour cells undergoes cell cycle 
dependent regulation.  Aurora must also be inactivated or 
degraded when the cell proceeds in G1  phase. The over-
expression of aurora in cultured cells produces a transformed 
phenotype, and transformed cells induce tumour formation 
when implanted in nude mice, indicating that the cell cannot 
function with a high level of aurora kinase activity (14). 
Expression of mammalian aurora proteins is cell cycle 
regulated, being maximal in G2/M phases (15-18). 
 
When cells exit from metaphase many proteins involved in the 
regulation of mitotic events are degraded via anaphase 
promoting complexes (APC) through a ubiquitin dependent 
pathway (7,9,19). Human aurora-A has been found to be Klotzbucher et al.   63 
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associated with APC/C (16), but although the kinase is 
ubiquitinated in vivo and degraded through a mechanism 
sensitive to APC/C inhibitors, a functional destruction box has 
now been identified.  
 
We report an assay that permits the ubiquitination analysis of a 
specific protein. Additonally, a degradation assay is performed 
to analyze the in vitro behaviour of this protein. This method 
analysis of any cell cycle regulated protein. 
 
MATERIALS AND METHODS 
 
Reagents 
 
1C1 and 6E3 monoclonal antibodies were directed against 
pAurora-A (20,21). 1C1 detects both the histidine-tagged and 
the endogenous aurora-A whereas 6E3 detects only the 
histidine-tagged protein (20). Bromodeoxyuridine (BrdU), 
primary monoclonal anti-BrdU antibody, aphidicolin, and 
trypsin-EDTA solution were obtained from Sigma. A 
secondary Texas-red conjugated antibody was obtained from 
Interchim. Leibovitz 15 cell culture medium (L-15), antibiotic-
antimycotic solution (penicillin-streptomycin-amphotericin) 
was supplied by GIBCO BRL laboratories. Foetal calf serum 
was obtained from Biotimes.  
 
Cell culture 
 
Xenopus XL2 cells were cultured and synchronized as 
previously described (22). Xenopus cells were cultured at a 
density of 10
5 cells in 75 cm
2 flasks in L-15 medium with 10% 
FCS until cell attachment. The cells were then washed three 
times with PBS and cultured in serum-free medium for 24 h. 
Flow cytometry was used to determine the degree of cell 
synchronization. Cells were synchronized for each phase as 
described above. For each step of synchronization, the cells 
were incubated in 40 µM BrdU, trypsinized and cell 
suspensions were centrifuged at 3,000 x g for 5 min, followed 
by fixation in ethanol at -20°C for 1 h. Fixed cells were treated 
with the anti BrdU antibody for 1 h (1/200) at room 
temperature and then with Texas-red conjugated 
immunoglobulin antimouse (1/50) for 1 h. Samples were stored 
at -20°C until analysis. Cells were stained with 10 µg/ml 
propidium iodide (PI) and DNA content was analyzed on a 
FACS (Becton Dickinson) with two fluorescence 
photomultipliers equipped with an argon laser operating at 15 
mW, generating a light of 488 nm wavelength. PI emission was 
measured at wavelengths between 620 and 655 nm. Cell cycle 
analysis was performed with multicycle program. 
 
Recombinant proteins 
 
The aurora-A encoding sequence was inserted in the bacterial 
expression vector pET21 (Novagen) as previously described 
(21). In this study we used a construct in which the two cyclin-
like “destruction boxes” were deleted by restriction enzyme 
digestions (11). All histidine-tagged recombinant proteins were 
purified from BL21(DE3)pLysS by Ni-NTA-agarose affinity 
chromatography following manufacturer's instructions (Qiagen 
S.A.). All the purified proteins proved to be soluble and were 
conserved in a buffer containing 20 mM Tris, pH7.5, 500 mM 
NaCl, and 50% glycerol at -20°C. 
 
In vitro ubiquitination assays 
 
The DNA coding for aurora-A  wt (wild type) inserted in 
Bluescript was in vitro transcribed/translated in reticulocyte 
lysate at 30°C for 2 hours using a TNT kit (ex: Promega T7 
quick translation kit). 2 µl of the translation reaction was added 
to a ubiquitination mix containing 40 mM Tris pH 7.5, 5 mM 
MgCl2, 1 mM DTT, 10% glycerol, 10 mM creatine phosphate, 
0.1 µg/ml creatine kinase, 0.5 mM ATP, 1 µM okadaic acid, 1 
µM ubiquitin aldehyde (Calbiochem), 1 mg/ml methylated 
ubiquitin (Sigma Chemicals) and 3.5 µl of Xenopus egg 
mitotic extract prepared according to Murray (1991) (23) in a 
total volume of 10 µl. The reaction was incubated for 60 
minutes at room temperature, stopped by the addition of 
Laemmli sample buffer and heated at 90°C for 10 min. 
Reaction products were separated by SDS-polyacrylamide gel 
electrophoresis and electrotransferred onto nitrocellulose 
membrane. Aurora-A (wt) and aurora-A ubiquitin conjugates 
were visualized by Western blots using the 6E3 monoclonal 
antibody. 
 
Cell extract preparation 
 
Cell extracts were prepared as described in Bastians et al 
(1999) (24) with some modifications. Cells were harvested by 
trypsin treatment and washed twice in ice cold PBS (136 mM 
NaCl, 26 mM KCl, 2 mM Na2HPO4, 2 mM KH2PO4, pH 7.2) 
and once in low salt buffer (LSB: 50 mM Hepes-NaOH pH7.5, 
5 mM KCl, 1.5 mM MgCl2, 1 mM DTT) supplemented with 
protease inhibitors mixture from Sigma Chemicals. The pellet 
was then resuspended in a lysis solution (50mM Hepes-NaOH 
pH7.4, 5mM KCl, 1.5mM MgCl2, 1mM DTT, 5 mM NaF, 5 
µg/ml leupeptin, 5 µg/ml pepstatin, 5 µg/ml chymostatin). The 
cells were homogenized in the buffer, incubated on ice for 20 
min and lysed by sonication at 4°C. Cellular debris was 
removed by centrifugation at 14,000 x g for 30 min. The 
supernatant was aliquoted and frozen in liquid nitrogen and 
stored at –80°C. 
 
In vitro degradation assay 
 
2 µl of thawed cell extract were supplemented with an ATP 
regenerating system (1.5 mM ATP, 40 mM phospho-creatine, 
80 µg/ml creatine kinase from Sigma Chemicals) and 
incubated with the recombinant purified protein in 7.4 mM 
Hepes pH 7.4, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT. The 
amount of recombinant protein added to the extract never 
exceeded the amount of endogenous protein to avoid any 
saturation of the degradation machinery. The reaction was 
incubated at 30°C and aliquots were taken at various time 
points. Protein degradation products were mixed with Laemmli 
sample buffers and separated on a 12.5% SDS-polyacrylamide Klotzbucher et al.   64 
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gel electrophoresis (7 cm x 12 cm), The gels were then 
electrotransferred on nitrocellulose membrane, in Tris-glycine 
100mM, methanol 20% buffer. The degradation product was 
then detected by Western Blot using the appropriate antibody 
followed by chemoluminescence and Quantification with the 
Image Quant software. Inhibition of the 26S proteasome was 
achieved by preincubating the cell extract with 40 µM ALLN 
(acetyl-leucyl-leucyl-norleucinal) during 30 min at 4°C 
(Calbiochem, San Diego, CA). 
 
Western blot analysis 
 
After electrophoresis and transfer onto the nitrocellulose 
membrane (Amersham Pharmacia Biotech) by standard 
methods, the membranes were blocked in TBST (20 mM Tris, 
pH 7.6, 137 mM NaCl, 0.1% Tween) containing 5% skimmed 
milk for 2 hours at 4°C. The membranes were incubated with 
specific monoclonal antibodies (1C1 or 6E3) for 1 hour at 4°C 
in TBST containing 2.5% skimmed milk and washed for 1 hour 
at 20°C in TBST containing 2.5% skimmed milk. The 
membranes were then incubated with peroxydase conjugated 
secondary antibody (Sigma Chemicals) for 2 hours in TBST 
with 2.5% skimmed milk. The immunocomplexes were 
revealed using peroxydase chemoluminescent substrates 
according to the manufacturer's instructions (NEN Life 
Sciences) and analyzed on a FluoroImager (Molecular 
Dynamics) in order to quantify the signal. 
 
RESULTS AND DISCUSSION 
 
We attempted to determine if the overall level of the aurora-A 
kinase is constant throughout the cell cycle. According to the 
protocol describe previously, the XL2 cells were synchronized 
at various stages of the cell cycle (20). Sequential use of serum 
deprivation, aphidicolin treatment, release from S block and 
incubation of the cells with ALLN  (acetyl leucyl leucyl 
norleucinal-proteasome inhibitor) arrested the cells in G0, G1/S, 
G2 and M phase respectively. After release, the cells started 
another cell cycle and the degree of synchronization was 
determined by FACS analysis. The protein levels of the 
corresponding cell cycle phases were analyzed by western 
blotting. 
 
Using the anti aurora-A antibody 1C1, we analyzed aurora-A 
protein levels at the different stages of the cell cycle (Fig. 1A). 
In extracts from cells released from serum starvation, the 
protein was poorly detected suggesting that the protein is 
absent from the G1 cells. In the extract prepared from cells 
blocked in S phase by aphidicholin treatment, the western blot 
revealed that aurora-A increases in this stage. Accumulation of 
the aurora-A occurred 6 hours after release from the 
aphidicholin block. At this time, a large percentage of the cells 
are in G2 phase. Even higher amount of aurora-A is detected 
when cells were blocked in M phase with ALLN (acetyl-
leucyl-leucyl norleucinal). When cells were released from the 
ALLN block and progressed into another cell cycle, the amount 
of aurora-A declined rapidly. Six hours after release from the 
ALLN block, 85% of the cells were in G1 phase and the amount 
of pAurora-A was hardly detectable. For quantification, protein 
levels were normalized with γ-tubulin whose protein levels do 
not vary during the cell cycle (Fig. 1B). 
 
Fig. 1: Cell cycle-dependent expression of aurora A protein. 
XL2 cells were blocked at various stages of the cell cycle by 
serum starvation or treatment with the different drugs as 
described in material and methods. After release from the 
block, cells were harvested at different stages of the cell cycle. 
The cell lysates prepared from 5x10
5 cells were separated by 
SDS PAGE and analyzed by Western blot with XlAurora A 
antibody and anti-γ tubulin as a control. The appropriate portion 
of a blot (according to the molecular weight of proteins to be 
analyzed) was separately probed with anti xlAurora-A 
(dilution: 1/500) and anti γ tubulin (dilution: 1/200) for the 
internal control of quantity of protein (Fig. 1A). The cell cycle 
distribution was analyzed by BrdU analysis. Percentage of cells 
in different phases of the cell cycle was calculated (Fig. 1B). 
The membrane has been scanned on a fluoroimager (Molecular 
Dynamics) and quantification of the protein has been realized 
with Image Quant. 
Aurora-A is degraded in G1  phase  by the 
ubiquitin-proteasome pathway 
 
The above results indicate that pAurora-A starts to accumulate 
in S phase reaching its maximum in G2/M and disappears as 
cells enter in G1 of the next cell cycle. This leads to the 
suggestion that the decrease in aurora-A protein levels is due to 
an increase in its degradation rate. Sequence analysis of aurora-
A revealed the presence of a putative destruction box similar to Klotzbucher et al.   65 
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that found in mitotic cyclin implicating that aurora-A is also 
degraded by the ubiquitin /proteasome pathway via the APC 
complex (Fig. 2). 
 
 
Fig. 2: Diagram to compare the amino acid sequences of the 
destruction boxes and flanking sequences  of cyclin B1, cyclin 
B2 and aurora-A. The destruction boxes are marked by a 
rectangle and the conserved amino acids are indicated in bold. 
 
We therefore investigated if aurora-A is ubiquitinated like the 
cyclins during M phase. We established an ubiquitination assay 
in a metaphase arrested Xenopus egg extracts (CSF extract). 
This extract is known to contain all the enzymes required for 
ubiquitination (described in the introduction) necessary for 
mitotic degradation. The ubiquitination reaction was performed 
with in vitro translated aurora-A the “wild type” or the 
“destruction box mutant” (data not shown) in the presence of 
ubiquitin aldehyde and methylated ubiquitin. Ubiquitin 
aldehyde was added to the reaction to compete with 
isopeptidases, which remove ubiquitin molecules from its 
substrates. Methylated ubiquitin was used to prevent the 
formation of polyubiquitin chains that would result in distinct 
higher molecular weight bands rather then a higher molecular 
weight smear. Although the presence of the CSF extract was 
not absolutely required for the ubiquitination its presence 
significantly stimulated the reaction (compare Figure 3, Lanes 
1 and 4). Ubiquitination of aurora-A could not be detected in 
the absence of ubiquitin aldehyde and methylated ubiquitin 
(Figure 3, Lane 2) or in the in vitro mock-translated reaction 
(Figure 3, Lane 3). In contrast, when ubiquitin aldehyde and 
methylated ubiquitin was added to aurora-A and incubated in 
the egg extract, ubiquitinated aurora-A conjugates were 
detected (Figure 3, Lane 1). 
 
Degradation assay in cell extract 
 
We demonstrated that Aurora A is ubiquitinated and therefore 
asked whether we could also show that is degraded in a cell 
free extract. As the protein disappears in G1 phase, we could 
not use metaphase arrested CSF even if the extract was 
released into G1 by the addition of calcium as aurora-A is not 
degraded in xenopus egg (data not shown). We decided to use a 
cellular extract from xenopus XL2 cells arrested in G1 phase. 
For this assay, we used purified proteins expressed in bacteria 
as it was easier to adjust the protein concentration than would 
be possible with the in vitro translated proteins. 
 
 
Fig. 3: Ubiquitination of p Aurora A in a xenopus cell 
extract.  In vitro-translated pAurora A was incubated in 
Xenopus CSF arrested eggs extracts (35 µg of protein) in the 
presence of 1µM ubiquitin aldehyde and 1mg/ml of methylated 
ubiquitin (Lane 1). Lane 2: ubiquitin aldehyde and methylated 
ubiquitin were omitted from the reaction. Lane 3: without in 
vitro translation of pAurora-A. Lane 4: without CSF extract the 
reactions were stopped, analyzed on SDS-PAGE and 
transferred onto nitrocellulose membrane.  Western blot 
analysis was performed with the monoclonal antibody ICI 
(dilution 1:500) in order to detect the pAurora-A-ubiquitin 
conjugates (Published in FEBS Lett, 508: 149-152, 2001 and 
used with permission). 
 
The amount of recombinant pAurora-A (wt and DB mutant) 
added to the extract was carefully estimated to avoid any 
saturation of the degradation machinery (Fig. 4A). Xenopus 
cells were synchronized in G1 phase by serum deprivation and 
cell extracts were prepared as described in materials and 
methods. The recombinant pAurora-A (wt and BD mutants) 
was incubated in the G1 cell extract. Degradation of 
recombinant proteins was followed at different time points by 
western blot analysis. Figure 4B shows that pAurora-A wild 
type was degraded more rapidly than the destruction box 
mutant (pAurora-A ∆D1D2). When incubated in the G1 cell 
extract, 50% of the added wt pAurora-A was degraded within 
the first 30 minutes (Fig. 4B, first panel). Two hours after 
incubation, the protein level was reduced to 20% while there 
was no decrease in the amount of the destruction box mutant. 
 
In order to prove that the observed degradation was due to the 
proteasome activity, the reaction was also performed in the 
presence of the proteasome inhibitor ALLN (acetyl leucyl 
leucyl norleucinal). Under these conditions pAurora-A was no 
longer degraded (Fig. 4B, third panel). 
 Klotzbucher et al.   66 
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Fig. 4A: In vitro degradation assay of the ubiquitinated 
protein pAuroraA. A specific amount of the recombinant 
protein (Lane 1) was analyzed on a 12.5% polyacrylamide gel 
and compared with the endogenous protein from a G1 cell 
extract (Lane 2). Western blot analysis was performed with the 
monoclonal antibody 1C1 (dilution 1:500) in order to detect the 
recombinant pAurora-A and the endogenous protein. 
 
Fig. 4B: XL2 cells were arrested in G1  phase by serum 
starvation. Cell extracts were prepared with lysis buffer 
complemented with an ATP regenerating system and incubated 
in the presence of pAurora A wild type or pAurora A mdb 
(mutated destruction box). Samples were analysed on a 12.5% 
SDS-PAGE followed by a western blot performed with the 
1C1 monoclonal antibody. Degradation kinetics of the various 
recombinant aurora-A proteins containing potential destruction 
box deletions were performed in XL2 cell extracts prepared 
from G1 cells. The reaction was incubated at 30°C. The 
specificity of the degradation was controlled by addition of the 
APC/C inhibitor ALLN. Reaction products were separated by 
12.5% SDS-polyacrylamide gel electrophoresis and analysed 
by western blot using the 1C1 monoclonal antibody (1:200). 
Aliquots of the reaction were taken at 0, 15, 30 and 120 
minutes. Western blots were quantified with Imag Quant and 
the amount of protein detected at various time points was 
expressed as a percentage of the protein detected at t = 0 min 
(input). 
 
In summary, the paper describes two in vitro functional assays 
to analyse the ubiquitination / degradation pathway of a cell 
cycle regulated protein. The ubiquitination assay is performed 
with xenopus egg extract and allows the analysis of the 
ubiquitination of in vitro translated proteins. Although xenopus 
extracts are adequate to study the mechanism of ubiquitination, 
somatic cell extracts are more applicable to analyze the 
mechanism of degradation of a cell cycle regulated protein as 
one can prepare a cell extract at any specific stage of the cell 
cycle. 
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PROTOCOLS 
 
Cell culture  
 
1.  Xenopus cells were cultured in 100 x 20 mm culture dish,  (Falcon, BD Science) in L-15 medium (Leibovitz 15 –GIBCO 
BRL) 10% FCS (Biological Industries - European grade filtered on 0.0.07 µM) antibiotic and antimycotic (penicillin 
10000 units /ml; streptomycin 10000 µg/ml; amphotericineB  25 µg/ml) from GIBCO-BRL Lifes biotechnologies. 
2.  The cells were then washed three times with phosphate buffered saline PBS Dulbeccos without Ca
2+and Mg 
2+. 
3.  XL2 cells in the different phases of the cell cycle were obtained as follows:  
•  Wash the cells four times with PBS. 
•  Incubate the cells for 24h hours at 25°C in serum free medium L-15 to obtain cells in G1 phase. 
•  Wash the cell culture three times with PBS and incubate the cells at 25°C with full medium and aphidicholin 
(Sigma-Aldrich) at 2µg/ml for 30 h to obtain cells in S phase. 
•  Wash the cells three times with PBS and incubate them for 8 hours at 25°C in full medium to obtain cells in G2 
phase. 
•  At the end, incubate the cells for 7 hours at 25°C in the presence of full medium added with ALLN 40µg/ml to 
accumulate cells in M phase. 
FACS analysis 
 
For each step of synchronization, the cells were incubated in 40 µM BrdU, trypsinized and cell suspensions were centrifuged at 
3,000xg for 5 min, fixed in cold ethanol 70°at -20°C for 1 h. 
 
All the experiments are performed in 12 x 75 mm tubes (Falcon recommended for flow cytometers manufactured by Becton 
Dickinson). The cells were washed three times with ice cold PBS, and treated with HCl 4N for 30 min at room temperature (RT) 
and washed ten times with ice cold PBS in order to eliminate the HCl until the pH of the solution is 7.5. Then incubate the cells 
with PBT (PBS with 0; 2% Tween 20 (Sigma) and 1% BSA (Sigma)) during 30 min at room temperature. 
 
The antibody anti-BrdU was diluted in PBT (1/30) and incubated with the cells 30 min at RT. The secondary antibody, texas-red 
conjugated immunoglobulin antimouse diluted at 1/40 was added to the mixture during 1 h at RT. 
 
The cells were then washed with PBS and treated with propidium iodide (IP) to a final concentration of 10µg/ml. DNA content was 
analysed on a FACS (Becton Dickinson) with two fluorescence photomultipliers equipped with an argon laser operating at 15 mW, 
generating a light of 488 nm wavelength. PI emission was measured at wavelengths between 620 and 655 nm. Cell cycle analysis 
was performed with multicycle program. 
 
Recombinant protein production 
 
All the proteins are produced in bacteria as the following procedure.  
 
The DNA sequence was inserted in the bacterial expression vector pET21 (Novagen). The transformed BL21(DE3)pLysS bacteria 
were cultivated for 2 hours at 37°C in 2XTY medium (2XTY = bacto Agar 1.6%; bacto yeast extract 1%; and NaCl 85 mM pH 7.5) 
and 1% glycerol until the DO600 reached 0.7 units. Then the mixture was cooled to 25°C and the induction was performed under 
IPTG (Isoprpyl-bthiogalactopyranoside - Euromedex) at a final concentration of 1 mM at 25°C for 2 hours.  
 
At the end of incubation the culture medium was centrifuged at 4°C for 30 min at 5000 rpm (JA20-Beckman). The pellet was 
washed twice with PBS and was frozen at -80°C for 24 hours. 
 
The pellet was then resuspended in IMAC 5 (IMAC = Tris/Hcl 20 mM , Nacl 500mM , Glycerol 10%) and Imidazol (sigma) 5mM 
containing lysozyme (Sigam) 1mg/ml and PMSF (phenylMethylSulfonylFluoride-Sigma) at a final concentration of 1 mM. The 
solution was sonicated and centrifuged 30 min at 9000 rpm in 50 ml Oakridge tube (JA-20 Beckman).  Klotzbucher et al.   69 
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The final supernatant containing the histidine-tagged recombinant protein was purified from by Ni-NTA-agarose affinity 
chromatography (Qiagen S.A.). 100µl of agarose was loaded in a seringue and washed three times with the IMAC 5 buffer.  
 
The protein supernatant was loaded on the column. The column was then washed twice with 20 volumes of IMAC 5 and IMAC 20 
(IMAC + 20 mM imidazol). The histidine tagged protein was eluted with small volumes of IMAC 250 (IMAC + 250 mM 
imidazol). All the purified proteins prooved to be soluble were conserved in a buffer containing 20 mM Tris, pH7.5, 500 mM 
NaCl, and 50 % glycerol at -20°C.  
 
In vitro ubiquitination assay 
 
The DNA coding for the proteins was inserted in Bluescript and was in vitro transcribed/translated in reticulocyte lysate at 30°C 
for 2 hours using a TNT kit (ex: Promega T7 quick translation kit). The translation has to be realised immediatly before the 
ubiquitination assay and cannot be stored at minus -80°C for another ubiquitination assay.  
 
2 µl of the translation reaction were added to a ubiquitination mix containing 40 mM Tris pH 7.5, 5 mM MgCl2, 1 mM DTT, 10% 
glycerol, 10 mM creatine phosphate, 0.1 µg/ml creatine kinase, 0.5 mM ATP, 1 µM okadaic acid, 1 µM ubiquitin aldehyde 
(Calbiochem), 1 mg/ml methylated ubiquitin (Sigma Chemicals) and 3.5 µl of Xenopus egg mitotic extract (Murray et al., Nature, 
339: 280-286, 1989). 
 
The reaction was incubated for 60 minutes at room temperature, stopped by the addition of Laemmli sample buffer and heated at 
90°C for 10 min. Reaction products were separated by SDS-polyacrylamide gel electrophoresis and electrotransferred onto 
nitrocellulose membrane. 
 
Cell extract preparation  
 
Cells synchronized as previously described were harvested by trypsin treatment and washed twice in ice cold PBS (136 mM NaCl, 
26 mM KCl, 2 mM Na2HPO4, 2 mM KH2PO4, pH 7.2). 
 
The cells were resuspended in low salt buffer (LSB: 50 mM Hepes-NaOH pH7.5, 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT) 
supplemented with protease inhibitors mixture from Sigma Chemicals The cells were homogenised in the buffer, incubated on ice 
for 20 min and lysed by sonication at 4°C. The mixture was centrifuged for 30 min at 15 000 rpm, 4°C in a microfuge (Hearaus). 
 
The pellet was then resuspended in a lysis solution (50 mM Hepes-NaOH pH7.4, 5mM KCl, 1.5mM MgCl2, 1mM DTT, 5 mM 
NaF, 5 µg/ml leupeptin, 5 µg/ml pepstatin, 5 µg/ml chymostatin). The supernatant was aliquoted and frozen in liquid nitrogen and 
stored at -80°C. 
 
Degradation assay 
 
2 µl of thawed XL2 cell extract were supplemented with an ATP regenerating system (1.5 mM ATP, 40 mM phospho-creatine, 80 
µg/ml creatine kinase) (Sigma Chemicals) and incubated with the recombinant purified protein in 7.4 mM Hepes pH 7.4, 5 mM 
KCl, 1.5 mM MgCl2, 1 mM DTT. The amount of recombinant protein added to the extract has to be controlled comparing to the 
amount of endogenous protein in order to avoid any saturation of the degradation machinery.  
 
The reaction was incubated at 30°C and aliquots were taken at various time points. Protein degradation products were mixed with 
Laemmli sample buffers and separated on a 12.5% SDS-polyacrylamide gel electrophoresis (7cm x 12 cm). 